Easton Pharmaceuticals Receives Preliminary Proposal for Vagisan

- November 8th, 2016

Easton Pharmaceuticals and BMV Medica SA have received a preliminary proposal from a large pharmaceutical manufacturer for Vagisan, a diagnostic test for Bacterial Vaginosis.

Easton Pharmaceuticals (OTC PINK:EAPH) and BMV Medica SA have received a preliminary proposal from a large pharmaceutical manufacturer for Vagisan, a diagnostic test for Bacterial Vaginosis.
According to the press release:

The preliminary proposal comes after many months of negotiations and contains an upfront financial consideration for the Mexican Marketing Authorization, which was received in September. The proposal was received from a major, multi-national pharmaceutical company who possess products and sales in over 90% of the markets throughout the world and who understands the sales growth opportunities in Mexico and other parts of Latin America, which are some of the fastest growing territories in the world.

Read the full press release here.

Leave a Reply